Impact of Sentinel Lymph Node Biopsy on Physical Function of the Upper Limb – A Prospective Study in Patients with Early Breast Cancer
Association of Breast Surgery ePoster Library. Kohli P. 05/13/19; 257052; P008
Mr. Pavneet Kohli
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P008
Topic: Axilla
IntroductionSentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in breast cancer for clinically node negative patients. There have been some studies looking at upper limb morbidity after SLNB. We conducted a prospective study based on patient-reported functional outcomes after SLNB for early breast cancer. Methods Patients operated for a wide local excision and SLNB from February to November 2017 were included in the study. Patients were required to fill a validated Quick Dash (QD) questionnaire pre-operatively, at 2-weeks and at 3-months after SLNB procedure. The QD scores were calculated (Range 0-100) with higher score indicating poorer function. QD scores before and after surgery were compared. Results: 120 patients were included in the analysis. Ninety-nine patients met all the inclusion criteria. The mean pre-operative QD score was 8.45. This increased to 16.05 at 2-weeks and reduced to 13.35 at 3 months. In a subset of patients without pre-operative upper limb dysfunction [QD score10) increased after surgery and remained high at 3 months.ConclusionThe Quick Dash scores suggest that there is a temporary deterioration in upper limb function after SLNB in patients with normal shoulder function. Assessment of 12-month scores would be useful to evaluate long-term outcomes.
Topic: Axilla
IntroductionSentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in breast cancer for clinically node negative patients. There have been some studies looking at upper limb morbidity after SLNB. We conducted a prospective study based on patient-reported functional outcomes after SLNB for early breast cancer. Methods Patients operated for a wide local excision and SLNB from February to November 2017 were included in the study. Patients were required to fill a validated Quick Dash (QD) questionnaire pre-operatively, at 2-weeks and at 3-months after SLNB procedure. The QD scores were calculated (Range 0-100) with higher score indicating poorer function. QD scores before and after surgery were compared. Results: 120 patients were included in the analysis. Ninety-nine patients met all the inclusion criteria. The mean pre-operative QD score was 8.45. This increased to 16.05 at 2-weeks and reduced to 13.35 at 3 months. In a subset of patients without pre-operative upper limb dysfunction [QD score10) increased after surgery and remained high at 3 months.ConclusionThe Quick Dash scores suggest that there is a temporary deterioration in upper limb function after SLNB in patients with normal shoulder function. Assessment of 12-month scores would be useful to evaluate long-term outcomes.
P008
Topic: Axilla
IntroductionSentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in breast cancer for clinically node negative patients. There have been some studies looking at upper limb morbidity after SLNB. We conducted a prospective study based on patient-reported functional outcomes after SLNB for early breast cancer. Methods Patients operated for a wide local excision and SLNB from February to November 2017 were included in the study. Patients were required to fill a validated Quick Dash (QD) questionnaire pre-operatively, at 2-weeks and at 3-months after SLNB procedure. The QD scores were calculated (Range 0-100) with higher score indicating poorer function. QD scores before and after surgery were compared. Results: 120 patients were included in the analysis. Ninety-nine patients met all the inclusion criteria. The mean pre-operative QD score was 8.45. This increased to 16.05 at 2-weeks and reduced to 13.35 at 3 months. In a subset of patients without pre-operative upper limb dysfunction [QD score10) increased after surgery and remained high at 3 months.ConclusionThe Quick Dash scores suggest that there is a temporary deterioration in upper limb function after SLNB in patients with normal shoulder function. Assessment of 12-month scores would be useful to evaluate long-term outcomes.
Topic: Axilla
IntroductionSentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in breast cancer for clinically node negative patients. There have been some studies looking at upper limb morbidity after SLNB. We conducted a prospective study based on patient-reported functional outcomes after SLNB for early breast cancer. Methods Patients operated for a wide local excision and SLNB from February to November 2017 were included in the study. Patients were required to fill a validated Quick Dash (QD) questionnaire pre-operatively, at 2-weeks and at 3-months after SLNB procedure. The QD scores were calculated (Range 0-100) with higher score indicating poorer function. QD scores before and after surgery were compared. Results: 120 patients were included in the analysis. Ninety-nine patients met all the inclusion criteria. The mean pre-operative QD score was 8.45. This increased to 16.05 at 2-weeks and reduced to 13.35 at 3 months. In a subset of patients without pre-operative upper limb dysfunction [QD score10) increased after surgery and remained high at 3 months.ConclusionThe Quick Dash scores suggest that there is a temporary deterioration in upper limb function after SLNB in patients with normal shoulder function. Assessment of 12-month scores would be useful to evaluate long-term outcomes.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}